Status:
RECRUITING
Endothelial Dysfunction for Prognosis In Patients With preeClampSia
Lead Sponsor:
Heidelberg University
Conditions:
Preeclampsia (PE)
Hypertensive Disorder of Pregnancy
Eligibility:
FEMALE
18+ years
Brief Summary
Preeclampsia is a pregnancy-specific hypertensive disorder and can progress rapidly to severe adverse outcomes affecting both the mother and the fetus. Endothelial and microcirculatory dysfunction med...
Detailed Description
Preeclampsia is defined as hypertension combined with features of multi-organ dysfunction and can progress rapidly to severe adverse outcomes affecting both the mother and the fetus. Endothelial dysfu...
Eligibility Criteria
Inclusion
- singleton pregnancies
- Age ≥ 18 years
- Patient's ability to provide consent
- written informed consent
Exclusion
- Lack of consent
- Language barrier
- Dark to very dark skin type
- Severe fetal chromosomal/genetic/structural anomalies
- Laboratory changes in LDH, creatinine, or platelets due to other causes (e.g., isolated thrombocytopenia, e.g., immune thrombocytopenia, carcinoma)
Key Trial Info
Start Date :
May 8 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2027
Estimated Enrollment :
385 Patients enrolled
Trial Details
Trial ID
NCT06912477
Start Date
May 8 2025
End Date
July 1 2027
Last Update
May 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Heidelberg University Hospital, Department of Gynecology and Obstetrics
Heidelberg, Germany, 69120